Form 4: Haemonetics Corp Executive Roy Galvin Reports Acquisition of Shares and Stock Options

Roy Galvin, President, Global Plasma & BC at Haemonetics Corp, reports the acquisition of common stock and stock options.

Summary

• Roy Galvin, an officer at Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 16, 2025, Galvin acquired 6,755 shares of common stock in the form of restricted stock units (RSUs).
• Galvin also acquired 14,626 non-qualified stock options with an exercise price of $70.31.
• Following these transactions, Galvin beneficially owns 13,998 shares of common stock and 14,626 derivative securities.
• The RSUs vest in three equal annual installments starting on the first anniversary of the grant date.
• The stock options vest in annual increments of 25% beginning on the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by an executive. The acquisition of shares and options could be interpreted as a positive sign, but it's not definitive.

Positives

• The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting schedules for the RSUs and stock options suggest a multi-year incentive plan for the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The reported transactions may have a minor positive impact on shareholder sentiment, as they reflect an executive's increased stake in the company.

Key Dates

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, RSUs, Haemonetics Corp, HAE, Roy Galvin, securities